June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Evaluation of Teleophthalmology During The COVID-19 Pandemic At A Single Outpatient Clinical Practice
Author Affiliations & Notes
  • Rithambara Ramachandran
    Ophthalmology, New York University, New York, New York, United States
  • Zachary Elkin
    Ophthalmology, New York University, New York, New York, United States
  • Scott E Brodie
    Ophthalmology, New York University, New York, New York, United States
  • Eleanore Kim
    Ophthalmology, New York University, New York, New York, United States
  • Irina Belinsky
    Ophthalmology, New York University, New York, New York, United States
  • Douglas Lazzaro
    Ophthalmology, New York University, New York, New York, United States
  • Joseph F. Panarelli
    Ophthalmology, New York University, New York, New York, United States
  • Ilyse Haberman
    Ophthalmology, New York University, New York, New York, United States
  • Laurence Sperber
    Ophthalmology, New York University, New York, New York, United States
  • Lama A Al-Aswad
    Ophthalmology, New York University, New York, New York, United States
  • Footnotes
    Commercial Relationships   Rithambara Ramachandran, None; Zachary Elkin, None; Scott Brodie, None; Eleanore Kim, None; Irina Belinsky, Horizon Therapeutics (C); Douglas Lazzaro, None; Joseph Panarelli, Aerie Pharmaceuticals (C), Allergan Inc. (C), CorneaGen (C), Glaukos Corporation (C), New World Medical (C), Santen Pharmaceutical (C); Ilyse Haberman, None; Laurence Sperber, Glaukos Corp (C); Lama Al-Aswad, Aerie Pharmaceuticals, Inc (C), AI Optics (C), GlobeChek (I), New World Medical Inc. (F), Save Vision Foundation (F), Topcon Medical Systems Inc. (F), Verily (C), Zeiss (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1737. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rithambara Ramachandran, Zachary Elkin, Scott E Brodie, Eleanore Kim, Irina Belinsky, Douglas Lazzaro, Joseph F. Panarelli, Ilyse Haberman, Laurence Sperber, Lama A Al-Aswad; Evaluation of Teleophthalmology During The COVID-19 Pandemic At A Single Outpatient Clinical Practice. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1737.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The COVID-19 pandemic has necessitated a global paradigm shift regarding healthcare delivery, replacing the traditional in-office visit with a virtual platform, in order to limit viral exposure and spread. The purpose of this study is to evaluate agreement between the diagnosis and management of common eye diseases seen in virtual eye care visits versus traditional in-office visits.

Methods : This is a retrospective chart review of patients who presented to a single center for a video televisit between March and June 2020. Agreement was based on a qualitative comparison between the documented primary diagnosis and treatment plan at the first synchronous video visit and first subsequent in-office visit.

Results : During the NY State Lockdown, a single-center practice saw 779 distinct patients virtually. The most common diagnostic categories were Lids/Adnexa (29%), Cornea (18%), and Glaucoma (16%). Of these, 425 (55%) were subsequently seen at an in-office visit. When comparing the primary diagnosis at the two visits, a similar diagnostic code was maintained for 354 patients (83%). There were no known significant adverse outcomes for any patient seen virtually.

Medication changes were made at 268 (34%) video visits. These were guided by symptoms and external exams, although a minority were prophylactic or part of post-operative care. The new treatment plan was maintained for the same diagnosis at 50% of the subsequent in-office visits. Overall, there was an escalation of care for 131 patients (31%), a de-escalation of care for 32 patients (7.5%), and no change in management for 257 patients (60.1%) at the follow-up traditional office visit. Glaucoma patients were the most likely to require additional management (either drops or procedural intervention) when seen in the office.

Conclusions : Based on the results of this study, teleophthalmology provides a safe, feasible, and fairly accurate means of providing routine outpatient eye care.[1] There was an agreement in diagnoses between the virtual and traditional visit in 83% of patients and management plans remained unchanged for at least 60% of patients. Particularly given the importance of the ophthalmic exam, there are limitations to this model of care resulting in missed diagnoses or escalations of care. Addressing these limitations will require further investigation. 1. Tan et al., J Telemed Telecare, 2017.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×